Whole-genome resequencing data for large numbers of human individuals, as generated by the 1000 Genomes Project ([www.1000genomes.org](http://www.1000genomes.org)), provide unprecedented amounts of information about microevolutionary processes and demographic histories. Such inferences rely on either genotypic or allelic frequency information for each variable position, which constitute the data for downstream analyses and hypothesis testing.

The calling of single-nucleotide polymorphisms (SNPs) and genotypes and the estimation of allele frequencies from next-generation sequencing (NGS) has undergone rapid development, along with likelihood-based and Bayesian methods created to deal with challenges associated to heterogeneity in read quality and coverage ([@bib20]). In Phase I of the 1000 Genomes Project, genotypes were called using a combination of different approaches: first, primary call sets were independently generated by different centers with different sequencing platforms, alignment, and variant calling methods; then, a consensus SNP call set was generated and made publicly available ([@bib24]).

The data generated by the 1000 Genomes Project frequently have been used to make inferences about evolutionary processes affecting our species, including the detection of targets of natural selection ([@bib13]; [@bib26]; [@bib1]) and understanding the genetic basis of complex phenotypes ([@bib15]). In addition, the detailed catalog of genetic variation it provides across multiple human populations has been used to understand the processes affecting specific genes.

Among the well-documented targets of selection is the major histocompatibility complex region of the human genome, which harbors the highly polymorphic classical human leukocyte antigen (*HLA*) class I and II loci. The interest in these loci stems from their strong association to various autoimmune disorders ([@bib23]), susceptibility and resistance to infection ([@bib5]), and striking signatures of genetic variation indicating strong balancing selection ([@bib19]). Such types of investigations can naturally be extended to the analysis of the 1000 Genomes data, which provide a rich resource of population genetic variation within and around *HLA* genes.

Despite this interest, the use of NGS data for *HLA* loci is hampered by a major technical hurdle, which is the mapping of short sequence reads to genes that are both highly polymorphic and which constitute a multigene family. The high polymorphism may decrease the probability that short reads will be successfully mapped to the reference genome, in the event that the sequenced individual carries a variant that is highly diverged from that used in the index ([@bib20]). In addition, the fact that many *HLA* genes have close paralogues increases the chance that a read will map to two or more genomic regions, leading it to be discarded from most sequencing analyses pipelines, and thus decreasing the amount of usable information for genotype calling ([@bib25]).

In previous studies authors explored the applicability of NGS to genotype the *HLA* alleles of an individual, where an allele typically is defined as the haplotype determined by a combination of SNPs within a given *HLA* gene \[*e.g.*, [@bib10]; [@bib17]\]. To this end, [@bib10] proposed NGS methodologies in which different steps---from sample preparation to haplotype level allele calling---were adapted to deal with the issues of high polymorphism and paralogy of *HLA* genes. In this way, they were able to successfully validate their methodology in a study of 270 samples that had been typed previously by sequence-specific oligonucleotide hybridization, which they treated as a gold standard dataset. The same gold standard dataset was used by [@bib17], who also examined the reliability of calling *HLA* alleles using NGS, but using the 1000 Genomes alignment data, and showed that this publicly available dataset can be used for this purpose, after appropriate filters (*e.g.*, coverage) are applied.

Both [@bib10] and [@bib17] were interested in using NGS data to determine *HLA* alleles. Information regarding *HLA* alleles is of biomedical relevance because *HLA* genotypes often are an important covariate to account for in association studies, and *HLA* typing is critical to hematopoietic transplantation. In this study, however, we evaluate the quality of SNP level genotype calls from the 1000 Genomes at the *HLA* genes.

The analysis of genotype and allele frequencies for SNPs contained within *HLA* genes has proven of great value in biomedical and evolutionary studies, and the 1000 Genomes dataset is a resource used recurrently in this context. Examples of the use of *HLA* SNP data from the 1000 Genomes Project include: (1) In genome-wide association studies (GWAS), SNPs in *HLA* genes often are associated with phenotypes of interest, and it is useful to understand the prevalence of these variants in additional populations; (2) GWAS studies benefit from knowledge of the haplotype structure surrounding *HLA* genes, which can be inferred from the dense SNP data of the 1000 Genomes for multiple populations (*e.g.*, [@bib14]); and (3) when testing for selection, many studies have found strong evidence associated to the HLA region, using the 1000 Genomes as a source of polymorphism data (*e.g.*, [@bib16]).

All the aforementioned applications of the 1000 Genomes Project SNP data in *HLA* genes are dependent on the reliability of genotype calls at each SNP. However, no study to date has provided a detailed survey of the reliability of individual genotype calls and allele frequency estimates at the SNPs in *HLA* genes, despite their frequent usage. We address this issue, discuss likely causes for cases of incorrect genotype calls, and provide a list of reliable sites for the *HLA* loci in the 1000 Genomes data. As in previous studies ([@bib10]; [@bib17]), we used a dataset in which individuals had their *HLA* genes genotyped using Sanger sequencing as a gold standard to benchmark the genotypes called at the 1000 Genomes Project. However, differently from these other studies, which were interested in reconstructing the *HLA* haplotypes using NGS, here we have deconstructed the haplotypes determined from Sanger sequencing data into SNPs, and compared genotypes at the SNP level to the 1000 Genomes data. We took advantage of the recent availability of a dataset of Sanger sequencing based *HLA* genotyping of *HLA-A*, *-B*, *-C*, *-DQB1*, and *-DRB1* for 930 of the samples from the 1000 Genomes Project ([@bib11]). Our results have implications for other studies that use SNP data from the 1000 Genomes in order to estimate allele frequencies. Because *HLA* loci are the most polymorphic in the human genome, they most likely represent the worst case scenario for mapping bias and, consequently, allele frequency estimation error.

Methods {#s1}
=======

In this study, we compare NGS genotype calls and allele frequency estimates reported by the 1000 Genomes Project with those obtained in a study which used Sanger sequencing to genotype *HLA* genes. For the purpose of our analysis we assembled a dataset comprising the intersection of the 1000 Genomes and Sanger sequencing samples, resulting in 930 individuals from 12 populations. [Supporting Information](http://www.g3journal.org/content/suppl/2015/03/17/g3.114.015784.DC1/015784SI.pdf), [Figure S1](http://www.g3journal.org/content/suppl/2015/03/17/g3.114.015784.DC1/FigureS1.pdf) summarizes the preprocessing of both datasets, which preceded genotype and allele frequency comparisons.

1000 Genomes dataset (1000G) {#s2}
----------------------------

SNP genotypes were acquired from the chromosome 6 integrated Variant Call Format (VCF) file from version 3 of the 1000 Genomes Project Phase I data, which is available at <ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/release/20110521/> ([@bib24]). We selected only SNPs in exons encoding the antigen recognition sites (ARS), which are exons 2 and 3 for *HLA*-*A*, -*B*, and -*C* ([@bib2]) and exon 2 for *HLA-DQB1* and *-DRB1* ([@bib4]). Sites were selected based on the most inclusive coordinates of the RefSeq database in July 22, 2014 (see [File S1](http://www.g3journal.org/content/suppl/2015/03/17/g3.114.015784.DC1/FileS1.pdf)). Both SNP and sample selection were carried out using VCFtools v0.1.12b ([@bib6]).

*HLA* reference panel by [@bib11] (PAG2014) {#s3}
-------------------------------------------

[@bib11] typed class I *HLA-A*, *-B* and *-C*, and class II *HLA-DRB1* and *-DQB1* genes of 1266 individuals from 14 different populations in Africa, Europe, Asia, and America. The *HLA* sequence-based typing was performed with specific polymerase chain reaction amplification of ARS exons followed by Sanger sequencing. Data are available at the dbMHC Web site (<http://www.ncbi.nlm.nih.gov/gv/mhc/xslcgi.fcgi?cmd=cellsearch>; [@bib12]).

Data from [@bib11] are available in the form of *HLA* allele names per individual. Allele naming for *HLA* genes follows specific rules ([@bib18]). To summarize, allele names are composed of a letter indicating the locus, followed by 2−4 numeric fields separated by colons. Each numeric field indicates specific forms of variation: the 1st field distinguishes groups of alleles by serological type, and the following fields distinguish nonsynonymous polymorphisms, synonymous polymorphisms, and noncoding differences, respectively. To obtain SNP genotypes and frequencies from the Sanger sequencing data, we converted all allele names to their associated sequences for ARS encoding exons. Sequences were acquired from the IMGT (*i.e.*, international ImMunoGeneTics information system) database ([@bib22]), which keeps a well-curated repository of all known *HLA* allele sequences.

Our analysis was restricted to ARS exons because the *HLA* typing method used by [@bib11] only probed genetic variation in these specific exons. As a consequence, multiple *HLA* alleles are compatible with the sequencing results, because the sites that differentiate them are in other exons. This results in what we refer to as an "ambiguous allele call" for an *HLA* allele (*e.g.*, the allele is identified as B\*35:03, but we cannot establish whether it is B\*35:03:01 or B\*35:03:02, or a group of alleles is attributed to an individual, such as B\*35:02/B\*35:03/B\*35:04). Ambiguous allele calls also may happen when sequencing has low quality at bases that differentiate two alleles. In addition, there are also genotypic ambiguities, which occur when different pairs of alleles are compatible with the sequencing results. For individuals that bear ambiguous alleles, we created a consensus sequence in which ambiguous sites were reported with both possible alleles (*e.g.*, A/T, see [Figure S1](http://www.g3journal.org/content/suppl/2015/03/17/g3.114.015784.DC1/FigureS1.pdf)). In this way, we incorporate the uncertainty associated to the sequence-based typing into downstream analyses.

Although we cannot rule out technical errors in the Sanger sequencing that generated the PAG2014 data ([@bib11]), we assume that this method provides the most reliable estimate of *HLA* alleles (and hence SNP genotypes), and will serve as a standard to estimate the reliability of genotype calls and allele frequencies for the 1000 Genomes data ([@bib7]).

Genotype comparisons {#s4}
--------------------

We initially quantified how well the 1000G and PAG2014 data agreed with respect to genotype calls. Genotypes at each site in each individual were compared between the 1000G data and the PAG2014 data, here considered as a gold standard. In the case of sites with ambiguity (*e.g.*, T/A) in the PAG2014 data, if one of the two possible alleles matched an allele present in the 1000G, we considered this an allele match and PAG2014 was corrected, by attributing the allele present in the 1000G data to the ambiguous site. After correcting the ambiguous sites in PAG2014, we only considered genotypes to be a match if both alleles in 1000G were present in the PAG2014 data, at that site. Throughout this article, sites are numbered according to their position in the ARS exons coding sequences (1−546 at the class I loci and 1−270 at the class II loci).

Allele frequency comparisons {#s5}
----------------------------

After correcting all possible ambiguities in PAG2014 (as described previously), we calculated allele frequencies for SNPs in both datasets. By comparing the frequency of the reference allele in 1000G to its value in PAG2014, we assessed the accuracy of allele frequency estimation. The reference allele was defined as the allele present in the hg19 build of the reference sequence of the human genome. RefSeq IDs of the reference sequences used for each *HLA* gene are reported on [File S1](http://www.g3journal.org/content/suppl/2015/03/17/g3.114.015784.DC1/FileS1.pdf).

We computed the error in 1000G frequency estimates per site *i* (*FE~i~*) as follows:$$FE_{i} = f_{i,1000G} - f_{i,PAG2014}$$where $f_{i,1000G}$ and $f_{i,PAG2014}$ are the frequency of the reference allele at site *i* in 1000G and PAG2014, respectively. We also computed the mean absolute error in frequency estimates per gene as a mean of absolute $FE_{i}$ for all sites within a gene (MAE):$$MAE = \frac{1}{n}{\sum\limits_{i = 1}^{n}\left| {f_{i,1000G} - f_{i,PAG2014}} \right|}$$where *n* is the number of SNPs in the gene.

Coverage in 1000G {#s6}
-----------------

Sequencing coverage per individual per site was calculated from the 1000 Genomes Project phase I BAM files for the low coverage experiments using the genomeCoverageBed program from BEDTools ([@bib21]). BAM files are available on [ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/phase1/data/\[sampleID\]/alignment/](ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/phase1/data/[sampleID]/alignment/). Only low-coverage BAM files were used to estimate coverage because genotype likelihoods for the data we analyzed (1000 Genomes Project Phase I integrated VCF files) were estimated from this source. Genotype likelihoods were estimated from high coverage exome BAM files only for a minority of sites that were exclusively discovered on the exome experiments, and were not used in the coverage analysis (See [Table S1](http://www.g3journal.org/content/suppl/2015/03/17/g3.114.015784.DC1/TableS1.pdf)).

Testing for mapping bias {#s7}
------------------------

After demonstrating that there is an overestimation of reference allele frequency in the 1000G SNPs (see the section *Results*), we hypothesized that mapping bias was the underlying cause. To test this hypothesis, we examined whether reads carrying the alternative allele at a SNP are less likely to map to the reference genome than reads carrying the reference allele. First, for each *HLA* allele present in the PAG2014 dataset, we defined windows of 51 base pairs that were centered on each SNP (25 base pairs upstream and 25 base pairs downstream of the SNP, including non-polymorphic sites). The set of windows centered on a specific SNP was then separated in two groups: (i) those that carry the reference allele at the central site and (ii) those that carry the alternative allele at the central site. Next, all windows were compared with the reference genome (hg19) sequence (the same sequence that was used as an index in the 1000 Genomes Project), and the number of mismatches was counted, excluding the mismatch at the central SNP. If mapping bias was influencing allele frequency estimates, we expected that, for SNP positions with overestimation of the reference allele frequency in the 1000G, the alternative alleles would be flanked by additional alternative alleles (and thus have a greater mismatch count against the reference sequence).

Results {#s8}
=======

Genotypic mismatch frequency {#s9}
----------------------------

We found that, on average, 18.6% of genotypes were mismatched between 1000G and PAG2014 when individual genotypes for each site in the five classical *HLA* genes were compared, and exons with greater nucleotide diversity tend to have a greater proportion of genotype mismatches ([Figure S2](http://www.g3journal.org/content/suppl/2015/03/17/g3.114.015784.DC1/FigureS2.pdf)). We also observed that mismatches are specially concentrated on a few sites ([Figure 1](#fig1){ref-type="fig"}), with 18.7% of sites concentrating 50% of the mismatches over the five loci we analyzed.

![Genotype mismatches between the 1000G and PAG2014 datasets. Results per polymorphic site ("Position") and per individual (930 in total). Individuals are ordered by number of mismatches (individuals with less mismatches on top). Sites are numbered according to their position in ARS exons coding sequence. Dark squares indicate mismatches between genotypes in the two datasets. ARS, antigen recognition sites; HLA, human leukocyte antigen.](931f1){#fig1}

Reference allele frequency accuracy {#s10}
-----------------------------------

Accuracy of estimation of allele frequencies in 1000G was assessed comparing the observed frequency of the reference allele in the 1000G data with that of PAG2014, for both the global dataset (consisting of a pooled set of all individuals) and for each population separately (see [Figure S3](http://www.g3journal.org/content/suppl/2015/03/17/g3.114.015784.DC1/FigureS3.pdf), [Figure S4](http://www.g3journal.org/content/suppl/2015/03/17/g3.114.015784.DC1/FigureS4.pdf), [Figure S5](http://www.g3journal.org/content/suppl/2015/03/17/g3.114.015784.DC1/FigureS5.pdf), [Figure S6](http://www.g3journal.org/content/suppl/2015/03/17/g3.114.015784.DC1/FigureS6.pdf), and [Figure S7](http://www.g3journal.org/content/suppl/2015/03/17/g3.114.015784.DC1/FigureS7.pdf)). We chose a difference of 0.1 between the frequencies on both datasets as a threshold that determines a "large frequency difference."

For the global dataset ([Figure 2](#fig2){ref-type="fig"}) we found that for *HLA-A* and *-C* most SNPs have similar frequency estimates for 1000G and PAG2014, with few large deviations (only 9/66 and 8/44 SNPs with absolute difference in frequencies ($\left| {FE} \right|$) larger than 0.1, respectively). The *HLA-DQB1* locus shows an intermediate proportion of SNPs with large deviations (10/42 SNPs with $\left| {FE} \right| > 0.1$), and *HLA-B* and *HLA-DRB1* show the greatest proportion of sites with large frequency differences between 1000G and PAG2014 (23/64 and 15/35 sites with $\left| {FE} \right| > 0.1$). Overall, the mean absolute difference in frequency between SNPs in the 1000G and PAG2014 data are 0.08, and it is greater at the *HLA* genes with the greatest levels of nucleotide diversity (*HLA-B*, *-DQB1* and *-DRB1* all deviate by $\pm 0.1$).

![REF allele frequency per site in each *HLA* gene in the 1000 Genomes (1000G) and Sanger sequencing (PAG2014) datasets. Continuous line indicates the expected relationship (*i.e.*, no difference) between 1000G and PAG2014. Dashed lines indicate a ±0.1 deviation from the expected frequency (as estimated from PAG2014 dataset). MAE (mean absolute error) defined in the section *Materials and Methods*. Numbers indicate site position in ARS exons sequence. REF, reference; ARS, antigen recognition sites; HLA, human leukocyte antigen.](931f2){#fig2}

The proportion of genotype mismatches and allele frequency deviations per site are highly correlated (Pearson correlation = 0.86, *P* \< 10^−16^; [Figure S8](http://www.g3journal.org/content/suppl/2015/03/17/g3.114.015784.DC1/FigureS8.pdf)). However, some SNPs with a high proportion of genotype mismatches have well-estimated allele frequencies. One example is site 465 at *HLA-B*, in which 44% of genotypes are mismatched, but $\left| {FE} \right|$ is only 0.007. Overall, 15 sites have more than 25% mismatched genotypes while showing $\left| {FE} \right| < 0.1$ (see [Figure S8](http://www.g3journal.org/content/suppl/2015/03/17/g3.114.015784.DC1/FigureS8.pdf)). This is possible when the frequency of genotype errors in which the reference allele is overrepresented is similar to the frequency of errors in which the alternative allele is overrepresented.

### Allele frequency at the axiom exome genotyping array -- Affymetrix: {#s11}

Because genotyping arrays constitute an additional frequently used resource to genotype SNPs within *HLA* genes, playing an important role in GWAS studies, we also have investigated the accuracy of allele frequency estimation from this genotyping technology. We estimated allele frequencies from Axiom Exome data, and we found that those allele frequency estimates are as reliable as the ones from the 1000 Genomes NGS data, at the same SNPs (see [Figure S9](http://www.g3journal.org/content/suppl/2015/03/17/g3.114.015784.DC1/FigureS9.pdf)).

Relationship between sequencing coverage and genotypic mismatches {#s12}
-----------------------------------------------------------------

To investigate whether low sequencing coverage could explain genotype mismatches and deviations from expected allele frequencies, we compared sequencing coverage between mismatched and matched genotypes ([Figure 3A](#fig3){ref-type="fig"}) and assessed the relationship between coverage and frequency deviation ([Figure 3B](#fig3){ref-type="fig"}).

![(A) Distribution of coverage (x-axis) at matched and mismatched genotypes; y-axis is the square root of the relative frequency (Mann-Whitney *U* one-tailed test, P \< 10^−16^); (B) Relationship between mean coverage (x-axis) and absolute frequency difference ($\left| {FE} \right|$, y-axis) between 1000G and PAG2014 (*r* = −0.11, *P* = 0.09). All polymorphic sites from *HLA-A*, *-B*, *-C*, *-DRB1*, and *-DQB1* genes are included in both *a* and *b*. HLA, human leukocyte antigen.](931f3){#fig3}

Sites with mismatched genotypes have on average lower sequencing coverage than sites with matched genotypes ([Figure 3A](#fig3){ref-type="fig"}; Mann-Whitney *U* one-tailed test *P* \< 10^−16^). This is the expected relationship if low sequencing coverage explains genotype mismatches between datasets. However, the difference in sequencing coverage between sites with matched and mismatched genotypes is small (mean coverage in matching genotypes is 1.95, and 1.75 in nonmatching genotypes, a difference of 6.2%) and has likely achieved very high significance only due to the large number of observations. Similarly, correlation between allele frequency deviation and sequencing coverage is weak and not significant ([Figure 3B](#fig3){ref-type="fig"}; *r* = −0.11, *P* = 0.09), although the direction of correlation is in agreement with what would be expected if lower coverage explained larger deviations in frequency estimation. We have also investigated the possible effect of the position of the SNPs relative to exon edges on the allele frequency deviations and found no correlation between those factors ([Figure S10](http://www.g3journal.org/content/suppl/2015/03/17/g3.114.015784.DC1/FigureS10.pdf)). We therefore investigated other factors that may account for errors in genotype calling.

Direction of frequency deviation {#s13}
--------------------------------

We found that most of the genotype mismatches are caused by miscalling an alternative allele as a reference allele ([Table S2](http://www.g3journal.org/content/suppl/2015/03/17/g3.114.015784.DC1/TableS2.pdf)). Furthermore, most deviations in allele frequency estimates are in the direction of an overestimation of reference allele frequencies in the 1000 Genomes data ([Figure 2](#fig2){ref-type="fig"}). This information is summarized in [Figure 4](#fig4){ref-type="fig"}, which shows the location and magnitude of frequency deviations between the 1000G and PAG2014 data.

![Difference in reference allele frequency between 1000G and PAG2014, measured by $FE$ (see the section *Materials and Methods*), at each polymorphic site, in each population. Shades of red indicate overestimation of reference allele frequency and shades of blue indicate underestimation of reference allele frequency in 1000G. Full population names are given in [Table S3](http://www.g3journal.org/content/suppl/2015/03/17/g3.114.015784.DC1/TableS3.pdf).](931f4){#fig4}

The overall shift in the direction of overestimating reference alleles is summarized in [Table 1](#t1){ref-type="table"}, which shows the number of SNPs with more than 0.1 frequency difference in at least two populations, for each locus. For *HLA-A*, *-B*, and *-DQB1* most sites with large frequency differences between 1000G and PAG2014 are skewed in the direction of overestimating the reference allele \[*P* = 0.057 for *HLA-A* and *P* \< 10^−4^ for *HLA-B* and *-DQB1*, binomial test for null hypothesis of equal numbers of deviations in direction of reference (REF) or alternative (ALT)\], whereas *HLA-C* and *HLA-DRB1* show no evidence for an excess of large deviations in the direction of reference alleles.

###### Number of sites with overestimation of REF or ALT allele frequency in each *HLA* locus ($\left| {FE} \right|$ \> 0.1 in 2 or more populations)

        *A*   *B*   *C*   *DQB1*   *DRB1*
  ----- ----- ----- ----- -------- --------
  REF   11    30    6     22       11
  ALT   3     2     3     2        11

Genomic coordinates of those sites are given in [Table S4](http://www.g3journal.org/content/suppl/2015/03/17/g3.114.015784.DC1/TableS4.pdf). HLA, human leukocyte antigen; REF, reference; ALT, alternative.

Testing for mapping bias {#s14}
------------------------

We hypothesized that the observed reference allele bias was caused by a lower efficiency in the mapping of reads containing the alternative allele. This is expected under the assumption that the reads carrying the alternative allele on average have more differences with respect to the reference genome (used by the 1000 Genomes Consortium as the index to align NGS reads) than reads carrying the reference allele. In this scenario, some sites would have a stronger bias than others if the alternative alleles in those sites are flanked by additional alternative alleles.

To test this hypothesis, we aligned sequences of all alleles present in PAG2014 to the *HLA* sequences present in the hg19 build of the reference human genome (the same sequences used for the alignment of reads in the 1000 Genomes Project) and defined windows of 51 base pairs around each SNP. We then quantified the number of differences with respect to the reference genome for windows surrounding (i) REF and (ii) ALT alleles. If REF allele mapping bias is driving errors in frequency estimation, it is expected that sites with an overestimation of REF allele frequency would present the following pattern: windows carrying the REF with fewer differences to the reference genome than sequences centered on the ALT alleles. For sites with well-estimated frequencies, on the other hand, we did not expect such a difference between REF and ALT windows.

To illustrate this effect, [Figure 5](#fig5){ref-type="fig"} shows the results for the two most extreme cases of frequency deviation shown in [Figure 4](#fig4){ref-type="fig"}: site 244 of *HLA-DQB1* and site 132 of *HLA-B* (0.56 and 0.52 absolute increase in REF allele frequency in the 1000 Genomes data with respect to PAG2014). In both cases, ALT windows bear more differences to the reference sequence than REF windows.

![Number of differences to the reference genome at 1860 51-bp windows centered at sites *HLA-B* 132 and *HLA-DQB1* 244 with reference (REF) or alternative (ALT) allele at those sites. Windows were defined from all *HLA* alleles present in the 930 samples from the PAG2014 dataset. HLA, human leukocyte antigen.](931f5){#fig5}

These results support the hypothesis that these sites with poorly estimated allele frequencies have their ALT alleles residing in haplotypes with substantially more differences with respect to the reference genome than haplotypes centered on the REF allele, thus accounting for the observed bias.

To gain a broader perspective of this issue, we classified SNPs from the *HLA* loci with REF allele bias (*HLA-A*, *-B*, and *-DQB1*) into three categories: (i) sites at which the REF allele frequency was overestimated, *i.e.*, $FE > 0.1$ ("*overestimated*"); (ii) sites where the REF allele frequency was underestimated, *i.e.*, $FE < - 0.1$ ("*underestimated*"); and (iii) sites at which allele frequencies were well estimated ($\left| {FE} \right| < 0.01$, here referred to as "*well estimated*"). We compared these three categories of sites with respect to the number of differences relative to the reference genome in REF and ALT windows ([Figure 6](#fig6){ref-type="fig"}). We found that the *overestimated* group has significant excess of differences at alternative allele bearing haplotypes. In this group of SNPs, ALT windows have on average 4.4 other differences relative to the reference genome, whereas those centered on the REF allele have 1.9 differences (excess of differences on windows centered on the ALT allele was tested with a one tailed Mann-Whitney *U* test; *P* \< 10^−16^). Sites with *well estimated* or *underestimated* REF allele frequency, on the other hand, do not show a similar excess of differences in the haplotypes bearing the ALT allele, although the difference between REF and ALT windows is statistically significant because of the large sample size (*well estimated*: ALT mean = 1.7; REF mean = 1.8; one tailed Mann-Whitney *U* test *P* \< 10^−16^; *underestimated*: ALT mean = 1.9 ; REF mean = 1.2; one tailed Mann-Whitney *U*, *P* \< 10^−16^).

![Number of differences to the reference genome at 51-bp windows centered at each SNP in the *HLA-A*, *-B*, and *-DQB1* genes. Windows around each SNP were defined from the set of 1860 alleles present in the 930 samples from the PAG2014 dataset. Next, the set of windows was divided in three groups: those centered on SNPs with *overestimated*, *well estimated* and *underestimated* reference allele frequencies (red, yellow and blue boxplots, respectively). Then, each group was divided in two: windows in which the central site contains the reference allele (REF, dark boxplots) and windows centered on an alternative allele (ALT, light colored boxplots). Upper and lower hinges correspond to the 25th and 75th percentiles, horizontal lines represent the median, whiskers are 1.5 times the interquartile range, and outliers are represented by dots. HLA, human leukocyte antigen; SNP, single-nucleotide polymorphism.](931f6){#fig6}

Impact of biases in frequency estimation to population genetic statistics {#s15}
-------------------------------------------------------------------------

Our analysis was able to identify a subset of SNPs in the *HLA* genes for which genotype calls and allele frequency estimates from the 1000G showed a high error rate with respect to the PAG2014 dataset. To evaluate the impact of the errors introduced by including these sites in population genetic analyses, we compared the distribution of sample heterozygosity between the sites with low and high error rates. Heterozygosity is defined as $H = 2p\left( {1 - p} \right)$ for biallelic loci, as is the case for the 1000 Genomes Phase I SNPs, because tri- or quad-allelic SNPs were not reported on Phase I.

The removal of sites with poor frequency estimates ($\left| {FE} \right| > 0.1$ in at least two populations) results in a marked change in the distribution of *H*, with a significant drop in the frequency of sites with large *H* and a shift in the distribution toward lower values ([Figure 7](#fig7){ref-type="fig"}). Note that the *H* values in [Figure 7](#fig7){ref-type="fig"} are estimated from the PAG2014 data, implying that the high values of *H* among "excluded" sites are not due to the deviations in allele frequencies generated by NGS errors, but are the true heterozygosities at those sites. These results therefore document that because sites with high heterozygosity tend to have greater deviations from the "true" frequency (*i.e.*, based on the PAG2014 dataset), the removal of poorly estimated sites results in a reduction in *H* values.

![Heterozygosity of SNPs at *HLA* genes estimated from the PAG2014 dataset. Orange bars show distribution of heterozygosity at sites with a high error rate in frequency estimation ($\left| {FE} \right| > 0.1$ in two or more populations). Blue bars show the distribution of heterozygosity after exclusion of SNPs with high error rate. SNP, single-nucleotide polymorphism; HLA, human leukocyte antigen.](931f7){#fig7}

The effect of heterozygosity on allele frequency estimation bias {#s16}
----------------------------------------------------------------

We found an overall positive correlation between SNP heterozygosity and the magnitude of error in allele frequency estimates ([Figure 8A](#fig8){ref-type="fig"}; Pearson's correlation = 0.32; *P* = 1.938 × 10^−7^). This result provides further evidence that sites with greater heterozygosity tend to have poorer estimates for allele frequencies in the 1000G. Also, heterozygosity is even more strongly correlated to the deviation in frequency, considering the direction of the deviation ([Figure 8B](#fig8){ref-type="fig"}; Pearson's correlation = 0.59; P \< 10^−16^). Together, these results show that *HLA* SNPs with greater heterozygosities not only have more errors in frequency estimation but also a stronger bias toward overestimation of REF allele frequency.

![Relationship between SNP heterozygosity (H) and (A) absolute value of deviation ($\left| {FE} \right|$; Pearson's correlation = 0.32; *P* = 1.938 × 10^−7^) or (B) magnitude and direction of deviation (*FE*; Pearson's correlation = 0.59; *P* \< 10^−16^). SNP, single-nucleotide polymorphism.](931f8){#fig8}

Discussion {#s17}
==========

The 1000 Genomes Project data were generated by various sequencing centers, which relied on different sequencing platforms, read lengths, aligners and variant and genotype calling algorithms ([@bib24]), creating challenges to an overall assessment of data reliability. In this study, we specifically examine the performance of NGS-based genotype calls and allele frequency estimates for the highly polymorphic and intensely studied classical *HLA* genes. We took advantage of the possibility of comparing downstream genotype calls from the 1000 Genomes and *HLA* typing based on Sanger sequencing for the same set of samples to assess data quality and test hypothesis about possible biases.

We show that the 1000 Genomes SNPs called in the *HLA* genes have many differences at the genotype level, when compared to results obtained using Sanger sequencing. However, considerably high genotype mismatching is possible with only modest deviations in allele frequencies, and we conclude that for the 1000 Genomes data allele frequency estimates for SNPs at *HLA* genes are considerably more reliable than the individual genotype calls.

Low coverage did not explain the errors in genotypes and allele frequencies in the 1000 Genomes dataset. Instead, we found evidence that read mapping bias was responsible for those errors. Mapping bias is well known for NGS, and highly polymorphic regions such as *HLA* genes are especially susceptible to its effects ([@bib20]), particularly when a single reference genome is used as an index for the alignment of NGS reads. In this situation, many true variants fail to be identified because they are present in haplotypes that differ from the genome used as index, and thus reads generated from these regions are not aligned and are lost. Together, these results suggest that increasing coverage would not improve allele frequency estimates at those sites if a single reference sequence is still used as index. By mapping to multiple genomes \[*e.g.*, using strategies similar to [@bib3] or [@bib9]\], it would be possible to improve genotype calling and allele frequency estimates.

In our study, *HLA-A*, *-B*, and *DQB1* show evidence of REF allele mapping bias. The *HLA-DRB1* locus, on the other hand, did not present REF allele frequency overestimation, a finding that can be explained by the existence of multiple copies of this gene (both pseudogenes and functional copies), which may result in biases/errors that make REF allele bias comparatively less visible ([@bib8]). The *HLA-C* locus also shows a weaker REF allele bias, a pattern that may be explained by its lower degree of polymorphism which leads to a decrease in the number of mismatches of reads with respect to the reference genome, thus decreasing the mapping bias.

We provide a list of unreliable SNPs within the *HLA* genes, defined by us as those with an absolute difference in frequency larger than 0.1 ($\left| {FE} \right| > 0.1$) in two or more populations ([Table S4](http://www.g3journal.org/content/suppl/2015/03/17/g3.114.015784.DC1/TableS4.pdf)). We show that these unreliable SNPs on average have greater heterozygosities in our gold standard dataset. As a consequence, although filtering out those unreliable sites improves the overall accuracy in allele frequency estimation, it leads to an underestimation of the mean heterozygosity of SNPs in *HLA* genes, a bias that should be taken into account in downstream analyses. Analyses that require genotype calls at the individual level, including haplotype-based analyses, should be performed with caution when using the data from the 1000 Genomes at *HLA* genes.

Our results have implications to studies that use SNP data from the 1000 Genomes in other genomic regions with high variability, such as KIR and olfactory receptors. Because *HLA* loci are the most polymorphic in the human genome, they represent a worst case scenario for mapping bias and subsequent allele frequency estimation errors. We found a significant correlation between SNP heterozygosity and the absolute difference in frequency between 1000 Genomes data and our gold standard. This suggests that in genome-wide studies, SNPs with high heterozygosities, and contained within regions with additional SNPs, have an increased chance of presenting poor frequency estimates.
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